Novo Nordisk A/S (TSX:NOVO)
Canada flag Canada · Delayed Price · Currency is CAD
19.66
-1.29 (-6.16%)
At close: Feb 4, 2026

Novo Nordisk Income Statement

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
309,064290,403232,261176,954140,800
Revenue Growth (YoY)
6.43%25.03%31.25%25.68%10.91%
Cost of Revenue
53,00843,56035,31928,42423,658
Gross Profit
256,056246,843196,942148,530117,142
Selling, General & Admin
67,86567,36861,59450,68341,058
Research & Development
43,80640,07231,07523,26317,199
Other Operating Expenses
45502-425-1,034-332
Operating Expenses
111,716107,94292,24472,91257,925
Operating Income
144,340138,901104,69875,61859,217
Interest Expense
-4,207-1,640-542-378-289
Interest & Investment Income
1,2691,8381,069239231
Earnings From Equity Investments
-17-1781-189-24
Currency Exchange Gain (Loss)
6,007-1,0231,652-4,651344
Other Non Operating Income (Expenses)
-241-289-197-181-122
EBT Excluding Unusual Items
147,151137,770106,76170,45859,357
Merger & Restructuring Charges
-9,366----
Gain (Loss) on Sale of Investments
71-1737-587296
Asset Writedown
-7,316-10,562-2,124-809-573
Pretax Income
130,540127,191104,67469,06259,080
Income Tax Expense
28,10626,20320,99113,53711,323
Net Income
102,434100,98883,68355,52547,757
Net Income to Common
102,434100,98883,68355,52547,757
Net Income Growth
1.43%20.68%50.71%16.27%13.33%
Shares Outstanding (Basic)
4,4434,4544,4834,5314,593
Shares Outstanding (Diluted)
4,4484,4634,4954,5454,606
Shares Change (YoY)
-0.34%-0.71%-1.10%-1.34%-1.58%
EPS (Basic)
23.0622.6718.6712.2610.40
EPS (Diluted)
23.0322.6318.6212.2210.37
EPS Growth
1.77%21.54%52.37%17.84%15.16%
Free Cash Flow
58,96273,80483,10266,74148,665
Free Cash Flow Per Share
13.2616.5418.4914.6910.56
Dividend Per Share
11.70011.4009.4006.2005.200
Dividend Growth
2.63%21.28%51.61%19.23%14.29%
Gross Margin
82.85%85.00%84.79%83.94%83.20%
Operating Margin
46.70%47.83%45.08%42.73%42.06%
Profit Margin
33.14%34.77%36.03%31.38%33.92%
Free Cash Flow Margin
19.08%25.41%35.78%37.72%34.56%
EBITDA
157,017145,691110,73681,11963,770
EBITDA Margin
50.80%50.17%47.68%45.84%45.29%
D&A For EBITDA
12,6776,7906,0385,5014,553
EBIT
144,340138,901104,69875,61859,217
EBIT Margin
46.70%47.83%45.08%42.73%42.06%
Effective Tax Rate
21.53%20.60%20.05%19.60%19.17%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.